Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000927356-99-000445
Filing Date
1999-03-25
Accepted
1999-03-25 00:00:00
Documents
3
Period of Report
1998-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K FOR PERIOD ENDED 12/31/98 10-K 244064
2 CONSENT OF ERNST & YOUNG LLP EX-23.1 761
3 FINANCIAL DATA SCHEDULE EX-27 2353
  Complete submission text file 0000927356-99-000445.txt   248809
Mailing Address 2950 WILDERNESS PLACE BOULDER CO 80301
Business Address 2950 WILDERNESS PLACE BOULDER CO 80301 3034496500
RIBOZYME PHARMACEUTICALS INC (Filer) CIK: 0000892112 (see all company filings)

EIN.: 341697351 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27914 | Film No.: 99573152
SIC: 2834 Pharmaceutical Preparations